The ACT Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across sites.

The goal of ACT is to support clinical trial recruitment with real-time prep-to-research counts across the network. ACT is available to all CTSA members, and researchers at the University of North Carolina at Chapel Hill. ACT is provided to UNC-Chapel Hill researchers at no charge; registration is required.

Accrual to Clinical Trials (ACT) Network

The ACT Network is a real-time platform allowing researchers to assess feasibility for clinical studies across sites.

The goal of ACT is to support clinical trial recruitment with real-time prep-to-research counts across the network. ACT is available to all CTSA members, and researchers at the University of North Carolina at Chapel Hill. ACT was developed collaboratively by members of the CTSA Consortium, with funding from the NIH National Center for Advancing Translational Science (NCATS).

What can you do with ACT?

  • Explore patient populations – Learn about your patient population in depth and in real time, from your desktop.
  • Find partner sites – Search for patients across the CTSA network to identify potential partners for multi-site studies.
  • Check feasibility of clinical studies – Iteratively test and refine inclusion and exclusion criteria to confirm the feasibility of your clinical study.
  • Demonstrate feasibility – Readily access patient counts for use in funding proposals and IRB submissions to demonstrate the feasibility of your clinical study.

Have questions about ACT? Email This email address is being protected from spambots. You need JavaScript enabled to view it..


Cite ACT

Publications based on research using the ACT Network must cite the NCATS ACT grant: "This project was supported by the National Institutes of Health through grant UL1TR000005 and UL1TR002489."

Any Intellectual Property derived from use of the ACT Network must cite the NCATS ACT grant: "This project was supported by the National Institutes of Health through grant UL1TR000005 and UL1TR002489."

Publications in which data source partners (hospitals) are to be identified by name will be reviewed for use of name only by each identified hospital prior to submission of a manuscript. At no time will specific participating data source partners be named unless explicitly approved by the data partner. Such approval must be requested and received in writing between the requestor and the Senior Vice President of Research, the Chief Information Officer, or their respective designee. Any entity (e.g., hospital) that does not agree to be identified by name as a data source will be instead identified as a "CTSA-affiliated hospital."

related services

NC TraCS Institute logo vertical

In partnership with:

Contact Us

Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social

Cite Us

CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2023 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact